Workflow
J&J(JNJ)
icon
Search documents
Johnson & Johnson to Participate in the Barclays 28th Annual Global Healthcare Conference
Businesswire· 2026-02-09 21:16
A live audio webcast of the presentation will be accessible through Johnson & Johnson's Investor Relations website at www.investor.jnj.com. An archived edition of the session will be available later that day. The audio webcast replay will be available approximately 48 hours after the webcast. thth NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the Barclays 28 Annual Global Healthcare Conference on Tuesday, March 10, 2026. Management will participate in a Fireside Chat at ...
J&J Posts Innovative Medicine Growth in 2025 Amid Stelara Patent Loss
ZACKS· 2026-02-09 15:25
Key Takeaways J&J's Innovative Medicine sales rose 4.1% organically to $60.4B in 2025 despite Stelara's LOE.JNJ saw growth led by Darzalex, Tremfya and Erleada, with new drugs contributing.J&J Stelara's LOE cut segment growth by 1,110 bps, with biosimilars launching in 2025.Johnson & Johnson (JNJ) has one of the most diverse revenue streams in the industry within its pharmaceuticals division, called Innovative Medicine. The company has several multi-million-dollar drugs covering a broad range of areas such ...
反者道之动,弱者道之用|财富非常道
重阳投资· 2026-02-09 07:31
前半句是世界观,讲的是万物运行之道,后半句是方法论,告诉人们遇到问题应当怎么做。 第 58 章则把这一原理具体落脚到"祸福相依"这样一个日常的智慧当中,使之成为了人人都可以理解 和掌握的方便法门。 在投资和商业管理中,这一智慧同样适用。 " 反者道之动,弱者道之用。天下万物生于有,有生于无。 "—— 《道德经》第 40 章 " 祸兮,福之所倚;福兮,祸之所伏。孰知其极?其无正也。正复为奇,善复为妖。人之迷,其日固 久。 "—— 《道德经》第 58 章 反者道之动,弱者道之用 作者/ 舒泰峰 重阳投资合伙人、财经作家 著有《财富是认知的变现》、《财富善战者说》等 "反者道之动,弱者道之用"是《道德经》的最精彩表述之一,它的意思是说道的运行规律是循环往复 的,物极必反;而道发挥作用的方式则是柔弱谦下,顺势而为。 (一) 1982 年 9 月 29 日早晨,芝加哥一位 12 岁的小女孩玛丽 · 凯勒曼由于感冒吃了一粒泰诺,几分 钟后倒地身亡。同一天,又有几名互不相识的受害者相继暴毙。警方发现,这些受害者唯一的共同点 就是服用了泰诺胶囊。经检测,胶囊里被混入了氰化物,含量是致死量的 100 倍。 全美陷入疯抢退货潮, ...
What is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill.
The Motley Fool· 2026-02-08 17:09
These companies pay very healthy dividends.Investors will often debate what makes a good dividend stock. For some, it's all about the dividend yield. Others highlight a company's dividend growth track record. The data suggests the sweet spot is right in the middle. Over the last 50 years, S&P 500 companies that increased their dividends delivered a 10.2% average annual return, while those with no change in their dividend policy (often higher-yielding stocks) returned 6.8% annually, according to data from Ne ...
On the Ground Diligence for the Sierra Leone Citizenship by Investment
The Wandering Investor· 2026-02-07 11:06
Group 1: Overview of Sierra Leone's Citizenship by Investment Program - The Sierra Leone Citizenship by Investment program offers a flexible and affordable pathway to citizenship, with a base price of $140,000 for the main applicant and discounts available for applicants of African descent [62][66] - The program allows for the inclusion of family members and business partners, making it one of the most affordable options globally for citizenship by investment [6][62] - The program is designed to attract high net worth individuals, providing them with opportunities to invest in a country with significant growth potential and low GDP per capita [46][47] Group 2: Economic and Investment Opportunities - Sierra Leone is focusing on sectors such as agriculture, infrastructure development, energy, and tourism to attract foreign direct investment [45][46] - The government is actively working to create a conducive environment for investors, including the establishment of the National Investment Board to facilitate investment processes [49][50] - The country offers unique opportunities for eco-tourism, with government support for developing eco-lodges and related infrastructure [52][55] Group 3: Banking and Financial Environment - Sierra Leone's banking sector is characterized by a focus on cash transactions, with no capital controls for local entities, making it easier for investors to manage their finances [26][33] - The banking system allows for efficient online banking services, enabling easy transfers and conversions without significant bureaucratic hurdles [31][33] - The country has not signed up for the Common Reporting Standard (CRS), providing a level of privacy for banking clients [26] Group 4: Political Stability and Governance - Sierra Leone is noted for its democratic stability, having undergone peaceful transitions of power, which enhances its attractiveness for foreign investment [22][39] - The government is committed to reforming immigration and investment laws to create a more favorable business environment [22][39] - The country has a strong emphasis on religious tolerance, which contributes to its social stability and peaceful coexistence among diverse communities [56][59] Group 5: Benefits of ECOWAS Membership - Citizenship in Sierra Leone provides access to the Economic Community of West African States (ECOWAS), allowing for easier travel and residence in 12 other West African countries [76][77] - This access simplifies the process for investors looking to expand their operations across the region, enhancing the overall value of Sierra Leonean citizenship [76][78] Group 6: Support for Investors - The Sierra Leone Citizenship by Investment program includes comprehensive support for new citizens, facilitating connections with government officials and providing assistance in navigating the investment landscape [70][72] - The program aims to remove bureaucratic obstacles, making it easier for investors to establish businesses and contribute to the local economy [74][75] - New citizens receive a free company setup and banking services, streamlining the investment process [70][72]
Jim Cramer Says Stocks Like Johnson & Johnson “Simply Refuse to Quit”
Insider Monkey· 2026-02-07 05:56
Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal! AI is eating the world—and the machines behind it are ravenous. Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink. Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and b ...
Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium
Businesswire· 2026-02-07 00:00
Core Insights - Johnson & Johnson announced 12-month pilot-phase data from the OMNY-AF study, indicating progress in their research efforts [1] - The company highlighted new findings related to the VARIPULSE Platform, suggesting advancements in technology and potential applications in the healthcare sector [1] Group 1 - The OMNY-AF study provides critical data that may influence future clinical practices and treatment options [1] - The VARIPULSE Platform's new findings could enhance the company's product offerings and competitive positioning in the market [1]
道指首破5万点创历史新高 分析师:市场已适应全球不确定性 投资者信心真实存在
智通财经网· 2026-02-06 23:49
Bolvin Wealth Management Group总裁Gina Bolvin表示,道指突破5万点"与其说是庆祝,不如说是一次确 认"。她指出,市场已经适应了更高利率、更慢的增长节奏以及全球不确定性,却仍能继续走高,这表 明投资者信心真实存在,2026年的市场焦点将更多回归企业基本面,而非货币政策。 智通财经APP获悉,周五,美股全面走强,道琼斯工业平均指数大涨逾1200点,涨幅约2.5%,盘中首次 突破5万点整数关口,收报50,115.67点,创下历史新高。 自2025年底以来,美股涨势逐步由科技板块向更广泛领域扩散,这一趋势显著利好道指成分股。尽管道 指同样包含英伟达(NVDA.US)、苹果(AAPL.US)和微软(MSFT.US)等科技巨头,今年推动指数上行的主 力,更多来自传统行业与防御型板块。其中,高盛(GS.US)、卡特彼勒(CAT.US)、安进(AMGN.US)以及 宣伟公司(SHW.US)等表现尤为突出。 由于道指采用价格加权方式计算,这些股价较高的成分股,对指数的影响力明显高于按市值加权的指 数。此外,波音近期股价同样持续走强,也对道指形成支撑。 回顾走势,自2024年5月首次站上4 ...
Johnson & Johnson Is a Resilient Blue-Chip Stock and It Just Hit New All-Time Highs
Yahoo Finance· 2026-02-06 15:50
Johnson & Johnson (JNJ) has a diversified business model that makes it resilient through economic cycles. JNJ is trading at new all-time highs. The stock maintains a 100% “Buy” technical opinion from Barchart. Analyst sentiment is mixed. JNJ has many “Strong Buy” opinions, but some analysts consider JNJ overvalued. Today’s Featured Stock Valued at $565 billion, Johnson & Johnson’s (JNJ) biggest strength is its diversified business model. It operates through pharmaceuticals and medical devices d ...
“脑科学”的新淘金热
3 6 Ke· 2026-02-06 13:37
长期以来,脑科学一直被视为医药研发中回报最不确定的领域之一。无论是阿尔茨海默病,还是精神分裂症等 精神疾病,复杂的病理机制使其成为研发失败的集中地。 当技术与市场确定性叠加,MNC也开始密集出手、并购与合作动作频出,投资者信心重启。 脑科学可能迎来一轮新的"淘金热"。 赛道逐步升温 关于升温最直观的信号,是研发和交易数量的同步上升。 以阿尔兹海默病(AD)为例,临床试验变得格外多。最新《2025年阿尔茨海默病药物研发管线》文章中统 计,目前有138种新药正在182项临床试验中进行评估,比2024年增长了9%,其中70%是针对全新机制的潜在疗 法。 而根据此前塔夫茨药物研究中心的数据,中枢神经系统药物的研发时间比非中枢神经系统药物长20%,审批时 间长38%。高风险、失败率也一度让资本和药企对这个赛道望而却步。 但近两年正在发生一个明显变化:脑科学赛道正在升温。原因在于,个别市场正迎来拐点。 一方面,以AD疾病为例的治疗药物开始兑现商业回报,销售额实现成倍增长。 另一方面,小分子、RNAi、细胞治疗、AI等前沿技术不断突破,让市场看到了新的可能。 此外,精神分裂症、抑郁症、双相障碍等精神疾病领域也在升温。IQV ...